Effectiveness of PARP inhibitor maintenance therapy (mPARPi) in advanced ovarian cancer (OC) by BRCA1/2 and HRD signature in real-world practiceDebra L. Richardson,Julia C. F. Quintanilha,Ryon Graf,Natalie Danziger,Christina Washington, Lauren E. Dockery,Tamara Snow, Anosheh Afghahi, Anthony Frachioni,Julia A. Elvin,Kathleen N. MooreJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
